111 related articles for article (PubMed ID: 14574626)
1. Cholesterol and Abeta aggregation.
Yanagisawa K
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S127-9. PubMed ID: 14574626
[TBL] [Abstract][Full Text] [Related]
2. Accelerated Abeta aggregation in the presence of GM1-ganglioside-accumulated synaptosomes of aged apoE4-knock-in mouse brain.
Yamamoto N; Igbabvoa U; Shimada Y; Ohno-Iwashita Y; Kobayashi M; Wood WG; Fujita SC; Yanagisawa K
FEBS Lett; 2004 Jul; 569(1-3):135-9. PubMed ID: 15225622
[TBL] [Abstract][Full Text] [Related]
3. Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease.
Fagan AM; Watson M; Parsadanian M; Bales KR; Paul SM; Holtzman DM
Neurobiol Dis; 2002 Apr; 9(3):305-18. PubMed ID: 11950276
[TBL] [Abstract][Full Text] [Related]
4. A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade.
Dolev I; Michaelson DM
Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13909-14. PubMed ID: 15365176
[TBL] [Abstract][Full Text] [Related]
5. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
[TBL] [Abstract][Full Text] [Related]
6. GM1 ganglioside and the seeding of amyloid in Alzheimer's disease: endogenous seed for Alzheimer amyloid.
Yanagisawa K
Neuroscientist; 2005 Jun; 11(3):250-60. PubMed ID: 15911874
[TBL] [Abstract][Full Text] [Related]
7. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.
Levi O; Dolev I; Belinson H; Michaelson DM
J Neurochem; 2007 Nov; 103(3):1031-40. PubMed ID: 17666042
[TBL] [Abstract][Full Text] [Related]
8. Examining the levels of ganglioside and cholesterol in cell membrane on attenuation the cytotoxicity of beta-amyloid peptide.
Lin MS; Chen LY; Wang SS; Chang Y; Chen WY
Colloids Surf B Biointerfaces; 2008 Sep; 65(2):172-7. PubMed ID: 18514493
[TBL] [Abstract][Full Text] [Related]
9. Murine synaptosomal lipid raft protein and lipid composition are altered by expression of human apoE 3 and 4 and by increasing age.
Igbavboa U; Eckert GP; Malo TM; Studniski AE; Johnson LN; Yamamoto N; Kobayashi M; Fujita SC; Appel TR; Müller WE; Wood WG; Yanagisawa K
J Neurol Sci; 2005 Mar; 229-230():225-32. PubMed ID: 15760644
[TBL] [Abstract][Full Text] [Related]
10. Independent effects of APOE on cholesterol metabolism and brain Abeta levels in an Alzheimer disease mouse model.
Mann KM; Thorngate FE; Katoh-Fukui Y; Hamanaka H; Williams DL; Fujita S; Lamb BT
Hum Mol Genet; 2004 Sep; 13(17):1959-68. PubMed ID: 15229191
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
[TBL] [Abstract][Full Text] [Related]
12. Formation of toxic Abeta(1-40) fibrils on GM1 ganglioside-containing membranes mimicking lipid rafts: polymorphisms in Abeta(1-40) fibrils.
Okada T; Ikeda K; Wakabayashi M; Ogawa M; Matsuzaki K
J Mol Biol; 2008 Oct; 382(4):1066-74. PubMed ID: 18692507
[TBL] [Abstract][Full Text] [Related]
13. Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease.
Dodart JC; Marr RA; Koistinaho M; Gregersen BM; Malkani S; Verma IM; Paul SM
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1211-6. PubMed ID: 15657137
[TBL] [Abstract][Full Text] [Related]
14. Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice.
Thal DR; Larionov S; Abramowski D; Wiederhold KH; Van Dooren T; Yamaguchi H; Haass C; Van Leuven F; Staufenbiel M; Capetillo-Zarate E
Neurobiol Aging; 2007 Aug; 28(8):1221-30. PubMed ID: 16815595
[TBL] [Abstract][Full Text] [Related]
15. GM1 ganglioside-mediated accumulation of amyloid beta-protein on cell membranes.
Wakabayashi M; Okada T; Kozutsumi Y; Matsuzaki K
Biochem Biophys Res Commun; 2005 Mar; 328(4):1019-23. PubMed ID: 15707979
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol depletion reduces aggregation of amyloid-beta peptide in hippocampal neurons.
Schneider A; Schulz-Schaeffer W; Hartmann T; Schulz JB; Simons M
Neurobiol Dis; 2006 Sep; 23(3):573-7. PubMed ID: 16777421
[TBL] [Abstract][Full Text] [Related]
17. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
18. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
Güntert A; Döbeli H; Bohrmann B
Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
[TBL] [Abstract][Full Text] [Related]
19. [Risk factors for Alzheimer's disease].
Yanagisawa K
Rinsho Shinkeigaku; 2000 Dec; 40(12):1225-7. PubMed ID: 11464462
[TBL] [Abstract][Full Text] [Related]
20. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
Fan J; Donkin J; Wellington C
Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]